BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15120371)

  • 1. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.
    Hall JJ; Loggie BW; Shen P; Beamer S; Douglas Case L; McQuellon R; Geisinger KR; Levine EA
    J Gastrointest Surg; 2004; 8(4):454-63. PubMed ID: 15120371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
    Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
    Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.
    Shen P; Hawksworth J; Lovato J; Loggie BW; Geisinger KR; Fleming RA; Levine EA
    Ann Surg Oncol; 2004 Feb; 11(2):178-86. PubMed ID: 14761921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
    Yang XJ; Huang CQ; Suo T; Mei LJ; Yang GL; Cheng FL; Zhou YF; Xiong B; Yonemura Y; Li Y
    Ann Surg Oncol; 2011 Jun; 18(6):1575-81. PubMed ID: 21431408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.
    Glehen O; Schreiber V; Cotte E; Sayag-Beaujard AC; Osinsky D; Freyer G; François Y; Vignal J; Gilly FN
    Arch Surg; 2004 Jan; 139(1):20-6. PubMed ID: 14718269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
    Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
    J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.
    Glehen O; Gilly FN; Arvieux C; Cotte E; Boutitie F; Mansvelt B; Bereder JM; Lorimier G; Quenet F; Elias D;
    Ann Surg Oncol; 2010 Sep; 17(9):2370-7. PubMed ID: 20336386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
    Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
    Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
    Stewart JH; Shen P; Russell GB; Bradley RF; Hundley JC; Loggie BL; Geisinger KR; Levine EA
    Ann Surg Oncol; 2006 May; 13(5):624-34. PubMed ID: 16538401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis.
    Gammon DC; Dutton T; Piperdi B; Zybert J; Wolfe SH; Nguyen E; Sbat D; Pillarisetty VG; Sullivan M; Whalen GF
    Am J Health Syst Pharm; 2009 Jul; 66(13):1186-90. PubMed ID: 19535657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.
    Krane LS; Kader AK; Levine EA
    J Surg Oncol; 2012 Mar; 105(3):258-60. PubMed ID: 22271499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
    Jacks SP; Hundley JC; Shen P; Russell GB; Levine EA
    J Surg Oncol; 2005 Aug; 91(2):112-7; discussion 118-9. PubMed ID: 16028284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.
    Levine EA; Stewart JH; Russell GB; Geisinger KR; Loggie BL; Shen P
    J Am Coll Surg; 2007 May; 204(5):943-53; discussion 953-5. PubMed ID: 17481516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
    Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
    Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
    Shen P; Levine EA; Hall J; Case D; Russell G; Fleming R; McQuellon R; Geisinger KR; Loggie BW
    Arch Surg; 2003 Jan; 138(1):26-33. PubMed ID: 12511145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.